Deep Phenotyping of Peripheral Blood Cells and Circulating Factors in Metabolic Diseases

Abroad (travel likely)Recruiting

Conditions

NAFLD · Diabetes Mellitus · Obesity

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University Study Center for Metabolic Diseases, Dresden, Saxony, Germany
Contact: Study coordinator (Nikolaos Perakakis, MD) · Nikolaos.Perakakis@ukdd.de · +49 351 458 13651
Contact: Study coordinator (Ingo Weigmann, MD) · Ingo.Weigmann@ukdd.de · +49 351 458 11723
Contact: Principal Investigator (Nikolaos Perakakis, MD)
Ingo Weigmann, MD (Sub-investigator)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

Obesity · Non-Alcoholic Fatty Liver Disease · Diabetes Mellitus, Type 2

Abroad (travel likely)Recruiting

Columbia, United States

OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities

Obesity and Type 2 Diabetes · NAFLD - Non-Alcoholic Fatty Liver Disease · Hypertension

Abroad (travel likely)Recruiting

Singapore, Singapore

Effects of VLCKD in Metabolic Syndrome

Diabetes Mellitus, Type 2 · Non-alcoholic Fatty Liver Disease · Obesity

Abroad (travel likely)Recruiting

Novara, Italy

Prevalence of NAFLD in T1DM Patients

NAFLD · Type 1 Diabetes · Fatty Liver, Nonalcoholic

Abroad (travel likely)Recruiting

Genk, Belgium